Claritev Corporation (CTEV)

Market Cap	336.43M
Revenue (ttm)	930.62M
Net Income (ttm)	-1.65B
Shares Out	16.20M
EPS (ttm)	-101.92
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	65,422
Open	22.21
Previous Close	21.96
Day's Range	20.60 - 22.21
52-Week Range	4.80 - 35.96
Beta	0.29
Analysts	Hold
Price Target	19.00 (-8.52%)
Earnings Date	May 7, 2025

About CTEV

Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1980
• Employees: 2,700
• Stock Exchange: NYSE
• Ticker Symbol: CTEV
• Website: https://www.claritev.com

Financial Performance

In 2024, Claritev's revenue was $930.62 million, a decrease of -3.21% compared to the previous year's $961.52 million. Losses were -$1.65 billion, 1694.9% more than in 2023.

Analyst Forecast

According to one analyst, the rating for CTEV stock is "Hold" and the 12-month stock price forecast is $19.0.

Price Target

$19.0

(-8.52% downside)

Analyst Consensus: Hold